Enhanced Efficacy of Direct-Acting Antivirals in Hepatitis C Patients by Coadministration of Black Cumin and Ascorbate as Antioxidant Adjuvants
Open Access
- 3 June 2020
- journal article
- research article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-10
- https://doi.org/10.1155/2020/7087921
Abstract
The widespread adaptation of a new generation of direct-acting antiviral agents (DAAs) unveils a superlative effect in the eradication of the hepatitis C virus (HCV). However, this therapy has been reported to exhibit vigorous side effects that pose a risk in fleet recovery. This study was conducted to investigate the efficacy of DAAs: sofosbuvir (SOF) and ribavirin (RBV), along with black cumin (BLC) and ascorbate (ASC), as adjuvants on hematological parameters; oxidative stress markers such as total antioxidant status (TAS), superoxide dismutase (SOD), reduced (GSH) and oxidized (GSSG) glutathione (GSH), gamma-glutamyl transferase (GGT), and malondialdehyde (MDA); liver function markers such as aspartate transaminase (AST), alanine aminotransferase (ALT), bilirubin, and alkaline phosphatase (ALP); and viral load with determined genotypes. HCV-infected patients (n=30) were randomly divided into two equal groups: control group (n=15) and treatment group (n=15). The control group was subjected only to SOF and RBV (400 mg each/day). Synergistically, the treatment group was administered with adjuvant therapy of BLC (250 mg/day) and ASC (1000 mg/day) along with DAAs (400 mg each/day) for 8 weeks. All selected patients were subjected to sampling at pre- and posttreatment stages for the assessment of defined parameters. The data revealed that the BLC/ASC adjuvant therapy boosted the efficacy of DAAs by reducing the elevated levels of liver markers such as AST, ALT, ALP, and bilirubin in the treatment group compared with those in the control group (P>0.05). The adjuvant therapy synchronously showed an ameliorating effect on hematological parameters. The SOF/RBV with adjuvant therapy also demonstrated an increasing effect in the activity of SOD, TAS, and GSH and a decreasing effect for GSSG, GGT, and malondialdehyde (MDA;P>0.05) followed by curtailing a RT-PCR-quantified viral load. Our findings provide evidence that systemic administration of BLC/ASC efficiently alleviates hematological, serological, and antioxidant markers as well as the viral load in hepatitis C patients. This highlights a potentially novel role of BLC and ASC in palliating hepatitis C.Funding Information
- Higher Education Commission, Pakistan
This publication has 59 references indexed in Scilit:
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- HCV and Oxidative Stress in the LiverViruses, 2013
- Vitamin C Is an Essential Factor on the Anti-viral Immune Responses through the Production of Interferon-α/β at the Initial Stage of Influenza A Virus (H3N2) InfectionImmune Network, 2013
- Protective effects of vitamin C against haematological and biochemical toxicity induced by deltamethrin in male Wistar ratsEcotoxicology and Environmental Safety, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology & Infection, 2011
- Hepatitis C virus‐induced oxidative stress and mitochondrial dysfunction: A focus on recent advances in proteomicsProteomics – Clinical Applications, 2010
- Increased Oxidative Stress, Decreased Total Antioxidant Capacity, and Iron Overload in Untreated Patients with Chronic Hepatitis CDigestive Diseases and Sciences, 2009
- Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertensionFundamental & Clinical Pharmacology, 2008
- Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis CJournal of Hepatology, 2008
- Development of Immunocompetence: Role of Micronutrients and MicroorganismsNutrition Reviews, 2002